This study investigates inoperable pancreatic cancer. It examines whether different schedules of administering investigational medication combined with another treatment have similar effects.
The study evaluates the safety and effectiveness of these treatment schedules. It looks at how well the treatments work and their side effects.
- Who can participate: Adults aged 18 and older with inoperable locally advanced or metastatic pancreatic cancer can participate. Participants must not have received standard systemic treatment recently and need to have measurable lesions.
- Study details: Participants will receive either a three-week or four-week treatment schedule.
How understandable was the trial content above?
Hard to understand
Easy to understand